Study guide
7.3 Tablet Splitting & Crushing Restrictions
PTCB Hazardous Drug Management Certificate Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
0.1 Exam Facts, Format & Eligibility 0.2 Content Outline, Scoring & Registration 0.3 USP <800> Big Picture & How to Use This Guide
2 USP <800> Program Administration
1.1 USP <800> Scope, Purpose & Enforcement 1.2 The NIOSH Hazardous Drug List (2024 Update) 1.3 Assessment of Risk 1.4 Designated Person, SOPs & the Hierarchy of Controls
3 Training, Compliance & Recordkeeping
2.1 Training Requirements & Medical Surveillance 2.2 Hazard Communication, SDS & OSHA Requirements 2.3 Recordkeeping & Professional Guidelines
4 Primary Engineering Controls
3.1 Containment Primary Engineering Controls (C-PEC): BSCs & CACIs 3.2 Closed System Transfer Devices (CSTDs) 3.3 Nonsterile Controls and the C-SCA Distinction
5 Secondary Engineering Controls & Facility Design
4.1 Containment Secondary Engineering Controls (C-SEC): Negative Pressure & Air Exchange 4.2 Facility Layout: Storage, Unpacking & Sink Placement 4.3 Certification, ISO Classes & Emergency Equipment
6 Facility Cleaning Procedures
5.1 The Four-Step Cleaning Process 5.2 Wipe Sampling & Action Levels 5.3 Hazardous Waste Disposal & RCRA
7 Spill Response & Cleaning PPE
6.1 Spill Kits & Spill Response Procedures 6.2 PPE During Cleaning: Glove Change Frequency & Disposal
8 Dispensing & the Compounding Interface
7.1 USP <795>/<797> Interface for Hazardous Drugs 7.2 High-Risk Oral Hazardous Drugs 7.3 Tablet Splitting & Crushing Restrictions
9 Counting, Packaging & Patient Counseling
8.1 Counting, Packaging & Dedicated Equipment 8.2 Patient Counseling & Unit-Dose Labeling
10 PPE: Gloves, Gowns & Task-Based Selection
9.1 ASTM D6978 Chemotherapy Gloves & Double Gloving 9.2 Chemo Gowns & Gown Change Frequency 9.3 Task-Based PPE Selection
11 Respiratory Protection, Eye Protection & PPE Sequencing
10.1 Respiratory & Eye/Face Protection 10.2 Donning & Doffing Sequence
12 Transport & Receiving
11.1 Receiving Hazardous Drug Shipments 11.2 Internal Transport & Storage 11.3 Damaged/Leaking Shipments & Chain of Custody
13 Exam Readiness & Final Review
12.1 Domain-by-Domain Quick Review 12.2 Common Exam Traps & Final Checklist
7.3 Tablet Splitting & Crushing Restrictions
Key Takeaways Explain This Topic AI
Splitting or crushing a hazardous oral tablet breaks its protective coating, aerosolizing drug powder and creating contamination risk for the handler and for any shared equipment used afterward.
Splitting/crushing is classified as manipulation, not simple counting — it removes the task from Assessment-of-Risk eligibility and requires full USP <795> nonsterile compounding standards plus USP <800> containment requirements together.
USP <800> and nonsterile compounding principles prohibit splitting or crushing hazardous tablets on an open, uncontained surface with shared equipment; if unavoidable, it requires dedicated HD-only equipment, a contained/ventilated space, and chemotherapy-rated gloves at minimum.
The preferred alternative to splitting or crushing at the counter is routing the request to compounding for a properly validated oral liquid formulation under full <795>/<800> standards.
Any equipment or surface contacted by a split or crushed hazardous tablet requires the full deactivation/decontamination/cleaning process, not a quick wipe.
Last updated: July 2026
Tablet Splitting & Crushing Restrictions
Patients need modified dosage forms all the time — a child who cannot swallow a tablet, a patient fed through a gastrostomy tube, a caregiver asking for “just half a dose.” For an ordinary oral drug, splitting or crushing a tablet is often a routine counter task. For a hazardous oral drug, the exact same physical action changes the entire safety picture, and this is one of the most heavily tested trap areas in the Dispensing Final Dosage Forms domain because it looks like nothing more than routine pharmacy work.
Why Splitting or Crushing Changes the Risk
An intact hazardous drug tablet is contained by its manufacturer coating; simple counting and dispensing — with single chemotherapy-rated gloves as the floor — is generally all that is required, and the task may even qualify for the Assessment of Risk pathway covered earlier in this chapter. Breaking that coating, by splitting, crushing, or otherwise altering the tablet, exposes the drug powder underneath. That powder can become airborne, settle on work surfaces, transfer to gloves and hands, and contaminate any shared equipment — a counting tray, a pill splitter, a spatula — that gets used afterward for an entirely different, non-hazardous prescription. This is precisely why splitting and crushing are classified as manipulation rather than simple counting: the act pulls the task out of Assessment-of-Risk eligibility and into full compounding territory, triggering USP <795>'s nonsterile compounding quality standards plus USP <800>'s containment requirements together — the same interface covered in section 7.1.
Manufacturers sometimes reinforce this risk directly: many hazardous oral drugs are produced as film-coated or otherwise non-scored tablets specifically to discourage splitting, and product labeling may explicitly warn against crushing. Treat a non-scored coating or an explicit “do not crush” labeling note as a reinforcing signal, not the only source of the restriction — the manipulation risk exists for hazardous drugs regardless of what the tablet's physical design happens to look like.
The Core Restriction
USP <800>, together with general nonsterile compounding principles, strongly discourages or prohibits splitting or crushing a hazardous oral dosage form on an open, uncontained surface using shared, non-dedicated equipment. If splitting or crushing a hazardous tablet is clinically unavoidable, it must happen using dedicated equipment reserved only for hazardous drugs, inside a properly contained and ventilated space, with the technician wearing chemotherapy-rated gloves at minimum.
Setting Acceptable? Why
Open retail counter, using the pharmacy's shared pill splitter, no PPE No No containment; aerosolized powder and residue on the shared splitter cross-contaminate the next, unrelated prescription that uses the same equipment
A dedicated hazardous-drug compounding area or certified containment primary engineering control, using splitting/crushing equipment reserved only for hazardous drugs, chemo gloves worn Yes Containment plus dedicated equipment protects both the technician and every subsequent non-hazardous task
Routing the request to compounding for a properly formulated oral liquid instead of splitting/crushing at the counter Yes, and generally preferred Avoids the manipulation risk altogether by producing a validated preparation under full USP <795> (or <797>, if sterile) plus USP <800> standards
Preferred Alternatives, in Order
Ask whether an alternative formulation already exists. Many hazardous drugs are available in more than one strength; a prescriber may be able to prescribe an existing tablet strength instead of asking for a split dose.
Route to compounding rather than splitting at the counter. A properly compounded oral suspension, prepared under USP <795> nonsterile compounding standards plus USP <800> containment (dedicated space, dedicated equipment, chemo PPE), is the preferred path when a patient genuinely cannot take the manufactured dosage form.
If splitting or crushing truly cannot be avoided, it should happen using dedicated, hazardous-drug-only equipment in a contained and appropriately ventilated space, with chemotherapy-rated gloves worn at minimum, followed by proper cleaning and disposal of contaminated materials and equipment.
Any surface or equipment that does contact a split or crushed hazardous tablet requires the full deactivation/decontamination/cleaning process covered in Chapter 5, not a quick wipe with an alcohol pad.
Realistic Scenario
A caregiver arrives with a new prescription for a hazardous drug tablet, with directions to crush it and mix it into applesauce for a patient with dysphagia. The pharmacy is busy, and the technician on duty is tempted to crush the tablet on the open dispensing counter with the shared pill crusher to keep the queue moving. That shortcut is exactly the error this section is built to catch: crushing is manipulation of a hazardous oral dosage form, not simple dispensing, and doing it on an open, uncontained surface with equipment used for other prescriptions creates both an exposure risk to the technician and a cross-contamination risk for the next patient's medication. The correct response is to decline the open-counter shortcut and route the task appropriately — either using dedicated hazardous-drug-only equipment in a contained space, or referring the request to compounding for a proper liquid preparation instead.